Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20181010041299N1Phase 2Completed
Phase 2 trial of midazolam in hypertension (HTN), sponsored by Shahroud University of Medical Sciences. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20181010041299N1.